Resveratrol
Resveratrol is a naturally occurring plant polyphenol of the stilbene class, chemically 3,5,4'-trihydroxy-trans-stilbene.
Resveratrol is a naturally occurring plant polyphenol of the stilbene class, chemically 3,5,4'-trihydroxy-trans-stilbene. It is produced by grapevines, berries, and peanuts as a phytoalexin in response to stress or infection, and is found most abundantly in grape skin and red wine. The trans isomer is the biologically predominant and most studied form. Like many polyphenols, resveratrol is poorly water-soluble and undergoes extensive first-pass glucuronidation and sulfation, giving it low oral bioavailability — a limitation that has driven formulation work including nanocarrier systems and spray-dried inhalable powders for pulmonary delivery.
Its biological activity is broadly attributed to antioxidant and anti-inflammatory effects. Resveratrol scavenges reactive oxygen species and supports endogenous antioxidant defenses, including glutathione and glutathione Peroxidase 4 (Gpx4), and it activates Nrf2-driven cytoprotective transcription via the p62-KEAP1-Nrf2 axis, a pathway linked to suppression of ferroptosis. It is widely characterized as an activator of Sirtuin 1 (Sirt1), an NAD+-dependent deacetylase implicated in metabolic regulation, autophagy, and cellular stress resistance, and it engages AMPK signaling in energy and lipid metabolism. Resveratrol also modulates Phosphatidylinositol 3-kinase (PI3K)/Protein kinase B (PKB) and Mtor signaling, dampens NF-κB-driven production of proinflammatory cytokines such as Interleukin-6 (IL-6), and suppresses NLRP3 inflammasome activation with downstream Caspase-1-mediated pyroptosis; effects on Caspase-3-dependent apoptosis and on Transforming growth factor-β1 (TGF-β1)-driven fibrosis have also been described.
These mechanisms underlie preclinical interest across a wide range of conditions. In neuroscience, resveratrol has been studied for neuroprotection in models of Alzheimer's disease, Parkinson's disease, and epilepsy, where oxidative stress, cellular senescence, and impaired autophagy contribute to injury; its capacity to cross the blood-brain barrier is a recurring consideration in this work. Metabolic applications include high-fat-diet obesity models, where thermogenic β3-adrenergic and AMPK signaling has been implicated, alongside longstanding interest in type 2 diabetes and cardiovascular disease. It is also examined in fibrosis and tissue-remodeling settings and for anticancer activity, and is frequently combined with other natural compounds such as curcumin, quercetin, hesperidin, and catechins. Despite extensive preclinical literature, resveratrol remains a dietary supplement rather than an approved drug, and clinical evidence for its benefits is not established.
Where the papers sit
34 papers from the last 6 months study resveratrol directly · updated from PubMed 15 Nov 2026
Study type 0 clinical trials · 1 observational · 3 human data · 27 preclinical · 3 unclassified
Themes one subject · 3 new directions
Those 34 are all about one subject.
-
Resveratrol Therapeutic Applications
Resveratrol is being explored across inflammatory, neurodegenerative, metabolic, infectious, and cancer settings. Delivery research increasingly uses liposomes, hydrogels, niosomes, transethosomes, and stem-cell-derived exosomes to improve stability, release, and tissue exposure. Reported effects include reduced neuroinflammation, ferroptosis in lung cancer, altered macrophage arachidonic acid metabolism, and improved antimicrobial treatment. Biosynthesis and disease-specific mechanisms remain early and heterogeneous, with no single therapeutic direction yet established.
Resveratrol is a light-switchable, isomer-specific regulator of mitochondrial Endonuclease G
The Caenorhabditis elegans study of paternal mitochondrial elimination and dopaminergic neurodegeneration treats resveratrol not as a uniformly acting antioxidant or therapeutic modulator, but as two interconvertible molecules with opposite biological effects: trans-resveratrol directly binds and stabilizes Endonuclease G and enhances its nuclease activity, whereas cis-resveratrol binds the Endonuclease G DNA-binding region, inhibits substrate access, and suppresses the same process 42296341Jun. This makes resveratrol’s stereochemical state and light exposure—not merely its dose or delivery system—determinants of activity, and assigns it a previously absent role in regulating mitochondrial elimination through direct Endonuclease G control.
Resveratrol is used as the engineered product of a methanol-utilizing microbial biosynthesis platform
In metabolically engineered Escherichia coli, the study treated resveratrol not as an administered therapeutic or delivery cargo but as the target product of a reconstructed pathway that combines plant stilbene-biosynthetic enzymes, enhanced malonyl-CoA supply, and synthetic methanol assimilation. The resulting platform increased resveratrol production and establishes microbial conversion of methanol into resveratrol as a distinct role outside the therapeutic and formulation categories represented by the other papers 42704429Sep.
Resveratrol is treated as a programmable synthetic building block for generating structurally diversified dimers
The biomimetic radical oligomerization study of five resveratrol dimers used resveratrol monomers as differentiated substrates for controlled radical coupling, producing several dihydrobenzofuran-containing natural-product architectures. In this work, resveratrol is neither the therapeutic agent nor the delivery payload but a chemically programmable precursor for molecular diversification, opening a synthetic-chemistry direction absent from the disease and formulation studies 42247673Jun.
Papers
The 34 papers from the last 6 months that study resveratrol directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Resveratrol Therapeutic Applications (34)
- Inhalable Multifunctional Liposomes Disrupt the Inflammation-Oxidative Stress Cycle for Acute Lung Injury Therapy. ACS nano · 10 Nov 2026 PMID 43007750
- Resveratrol induces ferroptosis to repress malignant progression of lung cancer cells. Oncology reports · 6 Nov 2026 PMID 42992567
- Development, optimization, and characterization of a mucoadhesive buccal gel loaded with curcumin, quercetin, and resveratrol for local drug delivery. Oral and maxillofacial surgery · 4 Nov 2026 PMID 42983105
- RES NPs/GelMA Sustained-Release Cryogel Modulates Macrophage Arachidonic Acid Metabolism and Angiogenic Microenvironment Promoting Diabetic Wound Healing. ACS applied materials & interfaces · 23 Oct 2026 PMID 42912867
- Exploring the potential of resveratrol-enriched cord mesenchymal stem cell derived exosomes in an in vitro Parkinson's model. Metabolic brain disease · 15 Oct 2026 PMID 42878928
- Resveratrol Improves Memory and Reduces Neuroinflammation in an MPS IIIB Mouse Model. Neurochemical research · 13 Oct 2026 PMID 42867588
- Inhibition of heparan sulfate synthesis by resveratrol in mucopolysaccharidosis type I and IIIB. Metabolic brain disease · 10 Oct 2026 PMID 42859275
- Resveratrol Ameliorates Brain Functions During Gestation in Mancozeb-Low-Dose-Induced Brain Disorders via Mitigating Inflammation, Lipid Peroxidation, Mitochondrial Dysfunction, DNA Damage, Cell Death, and Histopathological Alterations. Molecular neurobiology · 23 Sept 2026 PMID 42776320
- An integrative computational and experimental evaluation of natural compounds with potential to target LuxS in Klebsiella pneumoniae. Archives of microbiology · 15 Sept 2026 PMID 42742729
- Targeting tumor heterogeneity using an injectable gelatin hydrogel for the dual elimination of cancer cells and cancer stem cells. Biomaterials science · 15 Sept 2026 PMID 42740709
- Resveratrol-loaded human dental pulp stem cell-derived exosomes enhance the efficacy of blue LED-mediated antimicrobial photodynamic therapy against mature cariogenic biofilms. Lasers in medical science · 11 Sept 2026 PMID 42726144
- Metabolic engineering of Escherichia coli for methanol-assisted resveratrol biosynthesis. Bioprocess and biosystems engineering · 7 Sept 2026 PMID 42704429
- Designing chitosan-coated niosomes: advanced encapsulation strategies to control drug release, enhance stability, and improve therapeutic efficacy. Physical chemistry chemical physics : PCCP · 14 Aug 2026 PMID 42596821
- Ultrasound-assisted transglutaminase crosslinked gluten-peanut protein for efficient encapsulation and controlled release of resveratrol. International journal of biological macromolecules · 13 Aug 2026 PMID 42595160
- Dual-type dynamic covalent chitosan/whey protein/Sr-doped bioactive glass carriers for hydrophobic compounds: injectable hydrogels and porous scaffolds. Carbohydrate polymers · 12 Aug 2026 PMID 42586680
- PEG-400-Modified Transethosomes for Resveratrol Delivery: Enhanced Dermal Penetration and Collagen Remodeling over Dermarolling Strategies. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 5 Aug 2026 PMID 42556752
- Anti-carcinoembryonic antigen conjugated resveratrol/sunitinib-loaded polymeric nanoparticles for therapeutic enhancement in colorectal cancer. International journal of biological macromolecules · 14 Jul 2026 PMID 42448198
- A Combination of Artemisinin, N-acetylcysteine, Resveratrol, and Hesperidin Ameliorates Hippocampal Damage and Pathological Features in an Experimental Model of Alzheimer's Disease. Neurochemical research · 13 Jul 2026 PMID 42440180
- Resveratrol Alleviates Epilepsy-Induced Brain Damage via the P62-Keap1-Nrf2 Pathway: A Multi-Omics Study Integrating the Pilot Cohort, In Silico Analyses, and Experimental Validation. Free radical biology & medicine · 10 Jul 2026 PMID 42431470
- Resveratrol Ameliorates PTZ-Induced Seizure Activity and Diaphragm Muscle Dysfunction by Regulating Calcium Handling and Apoptotic Pathways in Rats. Molecular neurobiology · 9 Jul 2026 PMID 42426356
- Study on the Effects and Mechanisms of Resveratrol in Improving Cognitive Impairment in Aβ1-42-Induced Alzheimer's Disease Model Mice. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 7 Jul 2026 PMID 42412302
- Design and characterization of a resveratrol spray-dried inhalable formulation for pulmonary delivery with in vivo pharmacokinetic and toxicological evaluation. Drug delivery · 29 Jun 2026 PMID 42366507
- Uptake and predictors of newborn respiratory syncytial virus (RSV) immunisation with nirsevimab in Ireland's national pilot programme: a cross-sectional study. BMJ open · 22 Jun 2026 PMID 42331576
- Resveratrol Alleviates Neurogenic Bladder Fibrosis and Urothelial Pyroptosis by Inhibiting the AKT/mTOR Signaling Pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 19 Jun 2026 PMID 42319380
- A rapid, multiplex, one-pot CRISPR/Dx system for visual detection of influenza A, influenza B, and respiratory syncytial viruses. Analytical methods : advancing methods and applications · 16 Jun 2026 PMID 42299927
- Resveratrol isomers with opposing activities target endonuclease G to modulate neurodegeneration and mitochondrial elimination. Proceedings of the National Academy of Sciences of the United States of America · 15 Jun 2026 PMID 42296341
- Biomimetic Radical Oligomerization Enables the Total Synthesis of Five Resveratrol Dimers. Organic letters · 5 Jun 2026 PMID 42247673
- Bibliometric analysis of natural medicine in the treatment of Alzheimer's disease: Trends, hotspots, and emerging research fields. Journal of Alzheimer's disease : JAD · 30 May 2026 PMID 42216664
- Grape-derived exosome-like nanoparticles suppress nasopharyngeal carcinoma progression by targeting the FASN/MAPK axis. Cellular signalling · 26 May 2026 PMID 42191056
- Multifunctional hybrid lipid-polymeric nanoparticle enabling resveratrol and siRNA co-delivery for enhanced cutaneous wound repair. Colloids and surfaces. B, Biointerfaces · 24 May 2026 PMID 42177899
- Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry Profiling, Antioxidant, Antibacterial, and Antidiabetic Properties of Fagonia cretica L.: Insights From In Vitro and In Silico Approaches. ChemistryOpen · 21 May 2026 PMID 42168772
- Sodium alginate functionalized biocompatible selenium nanocarriers loaded trans-resveratrol for mitochondrial targeted HepG2 hepatocellular carcinoma inhibition study. Nanomedicine (London, England) · 21 May 2026 PMID 42165412
- Selenium nanoparticle-enhanced resveratrol suppresses pulmonary inflammation and fibrogenesis in silicosis via redox-mediated inflammatory pathway modulation. Inflammopharmacology · 20 May 2026 PMID 42159899
- Synergistic Chemoimmunotherapy of Hepatocellular Carcinoma via ROS-Responsive Carrier-Free Prodrug Nanoparticles. Nano letters · 20 May 2026 PMID 42159189
By study type
Observational studies and case reports (1)
- Uptake and predictors of newborn respiratory syncytial virus (RSV) immunisation with nirsevimab in Ireland's national pilot programme: a cross-sectional study. BMJ open · 22 Jun 2026 PMID 42331576
Human data, design not indexed (3)
- Development, optimization, and characterization of a mucoadhesive buccal gel loaded with curcumin, quercetin, and resveratrol for local drug delivery. Oral and maxillofacial surgery · 4 Nov 2026 PMID 42983105
- Resveratrol-loaded human dental pulp stem cell-derived exosomes enhance the efficacy of blue LED-mediated antimicrobial photodynamic therapy against mature cariogenic biofilms. Lasers in medical science · 11 Sept 2026 PMID 42726144
- A rapid, multiplex, one-pot CRISPR/Dx system for visual detection of influenza A, influenza B, and respiratory syncytial viruses. Analytical methods : advancing methods and applications · 16 Jun 2026 PMID 42299927
Preclinical: animal, cell and lab studies (27)
- Inhalable Multifunctional Liposomes Disrupt the Inflammation-Oxidative Stress Cycle for Acute Lung Injury Therapy. ACS nano · 10 Nov 2026 PMID 43007750
- Resveratrol induces ferroptosis to repress malignant progression of lung cancer cells. Oncology reports · 6 Nov 2026 PMID 42992567
- RES NPs/GelMA Sustained-Release Cryogel Modulates Macrophage Arachidonic Acid Metabolism and Angiogenic Microenvironment Promoting Diabetic Wound Healing. ACS applied materials & interfaces · 23 Oct 2026 PMID 42912867
- Exploring the potential of resveratrol-enriched cord mesenchymal stem cell derived exosomes in an in vitro Parkinson's model. Metabolic brain disease · 15 Oct 2026 PMID 42878928
- Resveratrol Improves Memory and Reduces Neuroinflammation in an MPS IIIB Mouse Model. Neurochemical research · 13 Oct 2026 PMID 42867588
- Inhibition of heparan sulfate synthesis by resveratrol in mucopolysaccharidosis type I and IIIB. Metabolic brain disease · 10 Oct 2026 PMID 42859275
- Resveratrol Ameliorates Brain Functions During Gestation in Mancozeb-Low-Dose-Induced Brain Disorders via Mitigating Inflammation, Lipid Peroxidation, Mitochondrial Dysfunction, DNA Damage, Cell Death, and Histopathological Alterations. Molecular neurobiology · 23 Sept 2026 PMID 42776320
- An integrative computational and experimental evaluation of natural compounds with potential to target LuxS in Klebsiella pneumoniae. Archives of microbiology · 15 Sept 2026 PMID 42742729
- Targeting tumor heterogeneity using an injectable gelatin hydrogel for the dual elimination of cancer cells and cancer stem cells. Biomaterials science · 15 Sept 2026 PMID 42740709
- Metabolic engineering of Escherichia coli for methanol-assisted resveratrol biosynthesis. Bioprocess and biosystems engineering · 7 Sept 2026 PMID 42704429
- Designing chitosan-coated niosomes: advanced encapsulation strategies to control drug release, enhance stability, and improve therapeutic efficacy. Physical chemistry chemical physics : PCCP · 14 Aug 2026 PMID 42596821
- Ultrasound-assisted transglutaminase crosslinked gluten-peanut protein for efficient encapsulation and controlled release of resveratrol. International journal of biological macromolecules · 13 Aug 2026 PMID 42595160
- Dual-type dynamic covalent chitosan/whey protein/Sr-doped bioactive glass carriers for hydrophobic compounds: injectable hydrogels and porous scaffolds. Carbohydrate polymers · 12 Aug 2026 PMID 42586680
- PEG-400-Modified Transethosomes for Resveratrol Delivery: Enhanced Dermal Penetration and Collagen Remodeling over Dermarolling Strategies. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 5 Aug 2026 PMID 42556752
- Anti-carcinoembryonic antigen conjugated resveratrol/sunitinib-loaded polymeric nanoparticles for therapeutic enhancement in colorectal cancer. International journal of biological macromolecules · 14 Jul 2026 PMID 42448198
- A Combination of Artemisinin, N-acetylcysteine, Resveratrol, and Hesperidin Ameliorates Hippocampal Damage and Pathological Features in an Experimental Model of Alzheimer's Disease. Neurochemical research · 13 Jul 2026 PMID 42440180
- Resveratrol Ameliorates PTZ-Induced Seizure Activity and Diaphragm Muscle Dysfunction by Regulating Calcium Handling and Apoptotic Pathways in Rats. Molecular neurobiology · 9 Jul 2026 PMID 42426356
- Study on the Effects and Mechanisms of Resveratrol in Improving Cognitive Impairment in Aβ1-42-Induced Alzheimer's Disease Model Mice. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 7 Jul 2026 PMID 42412302
- Design and characterization of a resveratrol spray-dried inhalable formulation for pulmonary delivery with in vivo pharmacokinetic and toxicological evaluation. Drug delivery · 29 Jun 2026 PMID 42366507
- Resveratrol Alleviates Neurogenic Bladder Fibrosis and Urothelial Pyroptosis by Inhibiting the AKT/mTOR Signaling Pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 19 Jun 2026 PMID 42319380
- Resveratrol isomers with opposing activities target endonuclease G to modulate neurodegeneration and mitochondrial elimination. Proceedings of the National Academy of Sciences of the United States of America · 15 Jun 2026 PMID 42296341
- Biomimetic Radical Oligomerization Enables the Total Synthesis of Five Resveratrol Dimers. Organic letters · 5 Jun 2026 PMID 42247673
- Grape-derived exosome-like nanoparticles suppress nasopharyngeal carcinoma progression by targeting the FASN/MAPK axis. Cellular signalling · 26 May 2026 PMID 42191056
- Multifunctional hybrid lipid-polymeric nanoparticle enabling resveratrol and siRNA co-delivery for enhanced cutaneous wound repair. Colloids and surfaces. B, Biointerfaces · 24 May 2026 PMID 42177899
- Liquid Chromatography-Electrospray Ionization-Tandem Mass Spectrometry Profiling, Antioxidant, Antibacterial, and Antidiabetic Properties of Fagonia cretica L.: Insights From In Vitro and In Silico Approaches. ChemistryOpen · 21 May 2026 PMID 42168772
- Sodium alginate functionalized biocompatible selenium nanocarriers loaded trans-resveratrol for mitochondrial targeted HepG2 hepatocellular carcinoma inhibition study. Nanomedicine (London, England) · 21 May 2026 PMID 42165412
- Synergistic Chemoimmunotherapy of Hepatocellular Carcinoma via ROS-Responsive Carrier-Free Prodrug Nanoparticles. Nano letters · 20 May 2026 PMID 42159189
Unclassified: not yet indexed with MeSH (3)
- Resveratrol Alleviates Epilepsy-Induced Brain Damage via the P62-Keap1-Nrf2 Pathway: A Multi-Omics Study Integrating the Pilot Cohort, In Silico Analyses, and Experimental Validation. Free radical biology & medicine · 10 Jul 2026 PMID 42431470
- Bibliometric analysis of natural medicine in the treatment of Alzheimer's disease: Trends, hotspots, and emerging research fields. Journal of Alzheimer's disease : JAD · 30 May 2026 PMID 42216664
- Selenium nanoparticle-enhanced resveratrol suppresses pulmonary inflammation and fibrogenesis in silicosis via redox-mediated inflammatory pathway modulation. Inflammopharmacology · 20 May 2026 PMID 42159899
Written from 34 PubMed abstracts, each one listed by PMID above. Last written: 2026-09-25 by GPT. Reviewed by a human editor on 2026-07-23. Drafted by language models from published abstracts; not medical advice.